InvestorsHub Logo
icon url

Rick_Sanchez

06/04/19 11:53 AM

#166977 RE: Drannac #166969

It's complete conjecture at this point, but I share the same sentiment as you. Illiad Research obviously had to see something behind the curtain with POTN's management committee that would have made logical sense for them to provide $2.6M in financing for a covertible price of .45

A company like Illiad would only make the investment if they had reason to believe that they could return alpha on their investment right?

Who knows if it was that they were nearing a deal with CVS/Walgreens or another national pharmacy chain. Who knows if it was their path to Nasdaq listing. We won't know what it looks like until we continue to see quarterly statements and progress made.

Personally I think the conversion price is a tell-tale sign of where they think this price will be - however, we should also pay attention to the maturity and conversion date of these notes. October 2020 and August 2021. A tremendous amount of growth can happen between now and then and if Illiad expects to be in the green by then, then hell, I'll stick around for the ride and reap long term gains.